2026 NPPES data Vascular Neurology Physician NPI 1427341601 M.D.
Verify on CMS →

NAVDEEP SANGHA, M.D.

Vascular Neurology Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
454
Medicare Part D claims · 85 beneficiaries · Vascular Neurology Physician avg: 378
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: NAVDEEP SANGHA, M.D. is a Vascular Neurology Physician ([object Object]) practicing in HOUSTON, Texas with a Medicare Part D prescribing footprint of 454 claims across 85 beneficiaries — 15% brand-name prescribing .

What stands out: NAVDEEP SANGHA, M.D. filed 454 Medicare Part D claims in 2023 across HOUSTON, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

NAVDEEP SANGHA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

NAVDEEP SANGHA, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 05/23/2011

NPI 1427341601

Primary specialty

Vascular Neurology Physician

Niche

555 US NPIs in this specialty

Medicare Part D claims

454 20% vs specialty avg

2023 prescription claims

Specialty avg: 378

Specialty distribution in Texas

How Vascular Neurology Physician compares to other specialties among Texas providers

Texas providers

Vascular Neurology Physician share within Texas

1. Vascular Neurology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Vascular Neurology Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Vascular Neurology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Vascular Neurology Physician ABMS/AOA estimate

Est. board-certified rate (Vascular Neurology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Vascular Neurology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NAVDEEP SANGHA, M.D. is a Vascular Neurology Physician provider practicing in HOUSTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1427341601. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NAVDEEP SANGHA, M.D. appears in the CMS NPPES registry as a Vascular Neurology Physician provider holding M.D. credentials at 4550 N BRAESWOOD BLVD, HOUSTON, TX, 77096, with a listed phone of (626) 272-2983. NPI 1427341601 was issued on 05/23/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SANGHA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 454 prescription claims written by this provider, covering 85 Medicare beneficiaries and totaling roughly $66K in drug spend, split 15% brand-name and 85% generic by claim count, with an opioid prescribing rate of 3.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Vascular Neurology Physician is a narrow specialty nationwide, with 555 enrolled providers across 47 states and an average of 378 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4550 N BRAESWOOD BLVD
HOUSTON, TX 77096

Provider Details

NPI 1427341601
Specialty Vascular Neurology Physician
Credentials M.D.
Gender Male
NPI Issued 05/23/2011

Hospital and facility affiliations

Facilities where NAVDEEP SANGHA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
LOS ANGELES, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to NAVDEEP SANGHA, M.D.. To verify NAVDEEP SANGHA, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

NAVDEEP SANGHA, M.D. — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 454 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

454
Total Claims
$66K
Total Drug Cost
85
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,236
Total Day Supply
36,224
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$58K
Generic Drug Cost
$8K
Opioid Claims
14 (3.1% rate)

Patient Demographics

Average Patient Age
75.6 years
Avg HCC Risk Score
1.55
Gender Split
45% female / 55% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Rosuvastatin Calcium
67
Atorvastatin Calcium
48
Amlodipine Besylate
31
Levetiracetam
26
Pradaxa
Dabigatran Etexilate Mesylate
24
Ezetimibe
19
Clopidogrel
Clopidogrel Bisulfate
16
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
14
Memantine Hcl
14
Eliquis
Apixaban
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Vascular Neurology Physician Overview

How NAVDEEP SANGHA, M.D. fits within the Vascular Neurology Physician landscape nationally.

555
Vascular Neurology Physician Providers in US
47
States with Vascular Neurology Physician
378
Avg Claims per Provider

NAVDEEP SANGHA, M.D.'s 454 claims are above the specialty average of 378.

Nearby Vascular Neurology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as SANGHA.

Compare Vascular Neurology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NAVDEEP SANGHA, M.D.'s specialty?
NAVDEEP SANGHA, M.D. specializes in Vascular Neurology Physician and practices in HOUSTON, Texas. Credentials: M.D..
How much does NAVDEEP SANGHA, M.D. prescribe under Medicare Part D?
In 2023, NAVDEEP SANGHA, M.D. wrote 454 Medicare Part D claims totaling $66K in drug costs for 85 beneficiaries.
Where is NAVDEEP SANGHA, M.D. located?
NAVDEEP SANGHA, M.D. is located at 4550 N BRAESWOOD BLVD, HOUSTON, TX, 77096. Phone: (626) 272-2983.
What is NAVDEEP SANGHA, M.D.'s NPI number?
NAVDEEP SANGHA, M.D.'s National Provider Identifier (NPI) is 1427341601, issued on 05/23/2011.
Does NAVDEEP SANGHA, M.D. prescribe more brand-name or generic drugs?
NAVDEEP SANGHA, M.D.'s prescribing is 15% brand-name and 85% generic drugs by claim count, with $58K in brand drug costs.
Does NAVDEEP SANGHA, M.D. prescribe opioids?
Yes, NAVDEEP SANGHA, M.D. had 14 opioid claims in 2023 with an opioid prescribing rate of 3.1%.
How many Vascular Neurology Physician providers are there in the US?
There are 555 Vascular Neurology Physician providers across 47 states in the US. The average Vascular Neurology Physician provider writes 378 Medicare Part D claims per year.
What drugs does NAVDEEP SANGHA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, NAVDEEP SANGHA, M.D.'s most frequently prescribed drugs include Rosuvastatin Calcium, Atorvastatin Calcium, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NAVDEEP SANGHA, M.D. accept Medicare?
NAVDEEP SANGHA, M.D. appears in CMS Medicare data with 454 Part D claims and 85 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NAVDEEP SANGHA, M.D.'s credentials?
NAVDEEP SANGHA, M.D.'s NPI is 1427341601 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology